[Skip to Content]
[Skip to Content Landing]
Article
December 1995

Task Force on Recurrent Respiratory Papillomas: A Preliminary Report

Author Affiliations

From the Department of Otolaryngology—Head and Neck Surgery, Eastern Virginia Medical School, Norfolk.

Arch Otolaryngol Head Neck Surg. 1995;121(12):1386-1391. doi:10.1001/archotol.1995.01890120044008
Abstract

Objective:  To obtain pilot data about the incidence, need for surgical intervention, and demographics of recurrent respiratory papillomas in the United States.

Design:  Otolaryngologists were surveyed using a questionnaire with structured and open-ended questions.

Participants:  One thousand board-certified otolaryngologists practicing in the United States as of January 1, 1993, through a random mailing list provided by the American Academy of Otolaryngology—Head and Neck Surgery and all active US members of the American Society of Pediatric Otolaryngology and the American Bronchoesophagological Association. A total of 1346 questionnaires were distributed.

Main Outcome Measures:  Physician's responses to questions about their current patient load of children and adults with recurrent respiratory papillomas, their surgical and anesthetic management of the disease, and their clinical experiences with risk factors for developing recurrent respiratory papillomas.

Results:  Projected totals for recurrent respiratory papillomas among children were 2354 new cases (95% confidence interval [CI], 1448 to 3260) and 5970 active cases (95% CI, 3465 to 8474), requiring 16 597 surgical procedures (95% CI, 6938 to 26 255) at a cost of $109 million (95% CI, $45 to $172 million) for March 1, 1993 to March 31, 1994. Projected totals for adult recurrent respiratory papillomas were 3623 new cases (95% CI, 2359 to 4887) and 9015 active cases (95% CI, 6435 to 11 591) requiring 9284 surgical procedures (95% CI, 6003 to 12 565) at a cost of $42 million (95% CI, $27 to $59 million) for March 1, 1993 to March 31, 1994. The incidence of recurrent respiratory papillomas among children is estimated at 4.3 per 100 000; among adults, 1.8 per 100 000. The carbon dioxide laser was favored by 92% of respondents. No consensus was reached on the role for cesarean section. Forty-six percent of respondents favored the use of a laser-safe endotracheal tube for anesthetic management.

Conclusion:  A registry of patients with recurrent respiratory papillomas would benefit future research protocols and provide long-term follow-up of patients.(Arch Otolaryngol Head Neck Surg. 1995;121:1386-1391)

References
1.
Jones S, Myers G.  Benign neoplasms of the larynx .  Otolaryngol Clin North Am . 1985;17: (1) :151-178.
2.
Morgan AH, Zitsch RP.  Recurrent respiratory papillomatosis in children: a retrospective study of management and complications .  Ear Nose Throat J . 1986; 65:19-28.
3.
Strong MS, Vaughan CW, Healy GB, Cooperband SR, Clemente MCAP.  Recurrent respiratory papillomatosis: management with the CO2 laser .  Ann Otol Rhinol Laryngol . 1976;85:508-516.
4.
Kashima HK, Shah F, Lyles A, et al.  A comparison of risk factors in juvenileonset and adult-onset recurrent respiratory papillomas .  Laryngoscope . 1992; 102:9-13.
5.
Kashima HK, Mounts P, Levanthal B, Hruban RH.  Sites of predilection in recurrent respiratory papillomatosis .  Ann Otol Rhinol Laryngol . 1993:102( (8) pt 1):580-583.
6.
Abramson AL, Steinberg BM, Winkler B.  Laryngeal papillomatosis: clinical, histopathologic and molecular studies .  Laryngoscope . 1987;97:678-685.Crossref
7.
Corbitt G, Zarod AP, Arrend JR, Longson M, Farrington WT.  Human papillomavirus (HPV) genotypes associated with laryngeal papilloma .  J Clin Pathol . 1988;41:284-288.Crossref
8.
Quiney RG, Wells M, Lewis FA, Terry RM, Michaels L, Croft CB.  Laryngeal papillomatosis: correlation between severity of disease and presence of HPV 6 and 11 detected by in situ DNA hybridization .  J Clin Pathol . 1989;42:694-698.Crossref
9.
Dickens P, Srivastava G, Loke SL, Larkin S.  Human papillomavirus type 6, 11 and 16 in laryngeal papillomas .  J Clin Pathol . 1991;165:243-246.
10.
Lindeberg H, Syrjänen S, Karja J, Syrjänen K.  Human papillomavirus type 11 DNA in squamous cell carcinoma and preexisting multiple papillomas .  Acta Otolaryngol (Stockh) . 1989;107:1-9.Crossref
11.
Mounts P, Shah KV.  Respiratory papillomatosis: etiological relation to genital tract papillomas .  Prog Med Virol . 1984;29:90-114.
12.
Cohen SR, Geller KA, Seltzer S, Thompson JW.  Papilloma of the larynx and tracheobronchial tree in children: a retrospective study .  Ann Otol Rhinol Laryngol . 1980;89:497-503.
13.
Terry RM, Lewis FA, Griffiths S, Wells M, Bird CC.  Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in-situ DNA hybridization .  J Pathol . 1987;153:245-248.Crossref
14.
Kashima HK, Kessis T, Mounts P, Shah K.  Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis .  Otolaryngol Head Neck Surg . 1991;104:191-195.
15.
Rihkaren H, Aaltonen LM, Syrjänen SM.  Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium .  Clin Otolaryngol . 1993;18:470-474.Crossref
16.
Cook TA, Brunchswig JP, Butel JS, Cohn AM, Goepfert H, Rawls WE.  Laryngeal papilloma: etiologic and therapeutic considerations .  Ann Otol Rhinol Laryngol . 1973;82:649-655.
17.
Strong MS, Vaughn CW, Healy GD.  Recurrent respiratory papillomatosis . In: Healy GB, ed.  Laryngo-Tracheo Problems in the Pediatric Patient . Springfield, III: Charles C Thomas Publisher; 1979:88-98.
18.
Quick CA, Kryzek RA, Watt SL, Faras AJ.  Relationship between condylomata and laryngeal papillomata clinical and molecular virological evidence .  Ann Otol Rhinol Laryngol . 1980;89:467-471.
19.
Hallden C, Majmudar B.  The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata .  J Reprod Med . 1986;31:804-807.
20.
Quick CA, Farris A, Kryzek R.  The etiology of laryngeal papillomatosis .  Laryngoscope . 1978;88:1789-1795.
21.
Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A.  Rarity of cesarean delivery in cases of juvenile onset respiratory papillomatosis .  Obstet Gynecol . 1986;68:795-799.
22.
Lindeberg H, Elbrond O.  Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984 .  Clin Otolaryngol . 1991;15:125-131.Crossref
23.
Bennett RS, Powell KR.  Human papillomavirus: association between laryngeal papillomas and genital warts .  Pediatr Infect Dis J . 1987;6:229-232.Crossref
24.
Levy PS, Lemeshow S.  Simply for Health Professionals . Belmont, Calif: Wadsworth Publishing Co; 1980.
25.
Rimell F, Maisel R, Dayton V.  In situ hybridization and laryngeal papillomas .  Ann Otol Rhinol Laryngol . 1992;101:119-126.
26.
Smith EM, Johnson SR, Pignatari S, Cripe TP, Turek L.  Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis .  Ann Otol Rhinol Laryngol . 1991;100:479-483.
27.
Sedlacek TV, Lindeheim S, Elder C, et al.  Mechanism for human papillomavirus transmission at birth .  Am J Obstet Gynecol . 1989;161:55-59.Crossref
28.
Tseng CJ, Lin CY, Wang RL, et al.  Possible transplacental transmission of human papillomaviruses .  Am J Obstet Gynecol . 1992;166:35-40.Crossref
29.
Lindeberg H, Elbrond O.  Laryngeal papillomas: clinical aspects in a series of 231 patients .  Clin Otolaryngol . 1989;14:333-342.Crossref
30.
Cole RR, Myer CM, Cotton RT.  Tracheotomy in children with recurrent respiratory papillomatosis .  Head Neck . 1989;11:226-230.Crossref
31.
Levanthal B, Kashima HK, Mounts P.  Long-term response of recurrent respiratory papillomatosis to treatment of lymphoblastoid interferon alpha-n1 .  N Engl J Med . 1991;325:613-617.Crossref
×